Cargando…

Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations

Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by progressive interstitial fibrosis. The clinical course of IPF can be unpredictable and may be punctuated by acute exacerbations. Although much progress is being made in unraveling the mechanisms underlying IPF, effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Yutaro, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013866/
https://www.ncbi.nlm.nih.gov/pubmed/27625576
http://dx.doi.org/10.4137/CCRPM.S39897
_version_ 1782452233125756928
author Nakamura, Yutaro
Suda, Takafumi
author_facet Nakamura, Yutaro
Suda, Takafumi
author_sort Nakamura, Yutaro
collection PubMed
description Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by progressive interstitial fibrosis. The clinical course of IPF can be unpredictable and may be punctuated by acute exacerbations. Although much progress is being made in unraveling the mechanisms underlying IPF, effective therapy for improving survival remains elusive. Longitudinal disease profiling, especially in terms of clinical manifestations in a large cohort of patients, should lead to proper management of the patients and development of new treatments for IPF. Appropriate multidisciplinary assessment in ongoing registries is required to achieve this. This review summarizes the current status of the diagnosis and clinical manifestations of IPF.
format Online
Article
Text
id pubmed-5013866
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-50138662016-09-13 Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations Nakamura, Yutaro Suda, Takafumi Clin Med Insights Circ Respir Pulm Med Review Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by progressive interstitial fibrosis. The clinical course of IPF can be unpredictable and may be punctuated by acute exacerbations. Although much progress is being made in unraveling the mechanisms underlying IPF, effective therapy for improving survival remains elusive. Longitudinal disease profiling, especially in terms of clinical manifestations in a large cohort of patients, should lead to proper management of the patients and development of new treatments for IPF. Appropriate multidisciplinary assessment in ongoing registries is required to achieve this. This review summarizes the current status of the diagnosis and clinical manifestations of IPF. Libertas Academica 2016-09-06 /pmc/articles/PMC5013866/ /pubmed/27625576 http://dx.doi.org/10.4137/CCRPM.S39897 Text en © 2015 the author(s), publisher and licensee Libertas Academica Ltd. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.
spellingShingle Review
Nakamura, Yutaro
Suda, Takafumi
Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
title Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
title_full Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
title_fullStr Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
title_full_unstemmed Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
title_short Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
title_sort idiopathic pulmonary fibrosis: diagnosis and clinical manifestations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013866/
https://www.ncbi.nlm.nih.gov/pubmed/27625576
http://dx.doi.org/10.4137/CCRPM.S39897
work_keys_str_mv AT nakamurayutaro idiopathicpulmonaryfibrosisdiagnosisandclinicalmanifestations
AT sudatakafumi idiopathicpulmonaryfibrosisdiagnosisandclinicalmanifestations